The FDA has approved two gene therapies for sickle cell disease, which use a patient’s own stem cells to prevent red blood cells from sickling, but come with risks and are expensive.
The FDA has approved two gene therapies for sickle cell disease, which use a patient’s own stem cells to prevent red blood cells from sickling, but come with risks and are expensive.
Get the best of The Community Voice directly in your email inbox.
Sending to: